ACCC, CMA, & NCCN News

The following information has been received by ANCO.

All ANCO Online LIstServ postings are archived at the ANCO Online ListSev blog available at http://anco-online.blogspot.com/.

****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published today and is available online at http://www.accc-cancer.org/mediaroom/newsletters/2009/media_ACCCNEWSLETTER_1-26-2009.html. ANCO is an Institutional Member of ACCC. This edition features:

Evaluate Your Capital and Strategic Planning at ACCC's Annual National Meeting

CMS Proposes Improvements to Cervical Cancer Proficiency Testing Program

Hot Off the Press: Highlights of the Newest Oncology Issues

New Report Offers Look at Trends in Oncology for 2009

Welcome Aboard to ACCC's Newest Members

Q&A on ACCC's Listserv: The Value of Oncology Social Workers

ACCC's CE Blackboard: Lung Cancer, Year in Review

Take Our Survey: Oncology Issues and ACCC's Website

State Medical Oncology Societies Host Membership Meetings


****CMA NEWS****
The California Medical Association's (CMA) Alert was published today and is available online at http://www.calphys.org/html/news.asp. This edition features:

United Healthcare Eliminates “Progressive Fee Schedule”

Medi-Cal Claims with Patient SSNs Will Be Denied Beginning 2/1

HHS Extends ICD-10 Deadline to 2013; CMA, AMA Continue to Advocate for an Eight Year Transition Plan

Palmetto Agrees to Eliminate Monitored Anesthesia Policy

Despite Escalating Budget Crisis State Will Not Delay Medi-Cal Payments

House Passes Children’s Health Insurance Bill; Senate Expected to Follow

CMA Launches Webinar Series

Federal Economic Stimulus Plan Contains $150 Billion for Health Care

Call for Data: Out-of-Network Underpayment and Rescission of Treatment Authorization

Benefit of the Week: Employment Practices Liability Insurance


****NCCN NEWS****
Adjuvant Therapy in Breast Cancer: From Testing to Treatment
Join members of the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines Panel to discuss the use of adjuvant therapy in the management of breast cancer. The program will focus on issues such as indications for systemic adjuvant therapy, predictive and prognostic factors in adjuvant treatment, endocrine therapy for women, targeted therapy for HER2-positive tumors, and the appropriate use of cytotoxic chemotherapy.

Adjuvant Therapy in Breast Cancer: From Testing to Treatment
(http://discoveryhealthcme.discovery.com/breast-cancer/breast-cancer.html)

Discovery Health offers the most flexible way to earn free CME credit. Watch online anytime via high-speed internet connection, download the podcast, or order the DVD. Complete the post-test and evaluation on-line and print your certificate right from your computer.

Faculty
Robert W. Carlson, MD
Stanford Comprehensive Cancer Center

Lori J. Goldstein, MD
Fox Chase Cancer Center

Clifford A. Hudis, MD
Memorial Sloan-Kettering Cancer Center

Program Overview
In response to the burgeoning data regarding patient risk assessment and the selection of adjuvant hormonal, biologic, and cytotoxic therapies, the NCCN, in conjunction with Discovery Health, has brought together members of the NCCN Breast Cancer Guidelines Panel to discuss the use of adjuvant therapy in the management of breast cancer. The program will focus on issues such as indications for systemic adjuvant therapy, predictive and prognostic factors in adjuvant treatment, endocrine therapy for women, targeted therapy for HER2-positive tumors, and the appropriate use of cytotoxic chemotherapy.

Educational Objectives
Following this activity, participants should be able to:

Describe various testing options for hormonal and HER2 status
Explain the limitations and strengths of existing risk assessment tools
Identify the role of tamoxifen therapy in hormone receptor-positive younger women
Describe the role of aromatase inhibitors and the data supporting their use in hormone receptor-positive postmenopausal women
Discuss the use of cytotoxic chemotherapy based on risk assessment
Summarize the role of trastuzumab in treatment of HER2-positive tumors in the adjuvant setting

Intended Audience

This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer.


NCCN 14th Annual Conference - Register Now
Register now (at http://www.nccn.org/professionals/meetings/14thannual/default.asp) for a continuing education event hosted by the National Comprehensive Cancer Network – NCCN 14th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™. This NCCN Conference will include a special roundtable discussion that will offer a multiple-perspective examination of issues addressing the definition of value across the myriad of diseases in cancer; how quality of care and value should be measured and quantified; and the distribution methods and availability of reimbursement for reporting, performing, and enhancing value in the delivery of cancer care.

Date: March 11 – 15, 2009
Place: The Westin Diplomat
3555 South Ocean Drive
Hollywood, Florida
Fee: Nurses $395
Physicians, Pharmacists, and Other Health Care Professionals (not including Industry) $495
Industry $1,495

If you register and then cannot attend, a substitute attendee may be sent in your place. A $50 administration fee will be charged for each substitution. The registration fee is not refundable.

NCCN 14th Annual Conference:
Clinical Practice Guidelines & Quality Cancer Care™
(http://www.nccn.org/professionals/meetings/14thannual/default.asp)

Roundtable Discussion:
Finding and Achieving Value in Cancer Care
Friday, March 13, 2009

Moderator:
Clifford Goodman, PhD
The Lewin Group

Panel:
Joseph S. Bailes, MD
American Society of Clinical Oncology

Stephen B. Edge, MD
Roswell Park Cancer Institute

Mark Fendrick, MD
University of Michigan Comprehensive Cancer Center

Scott Gotlieb, MD
American Enterprise Institute

Robert Mass, MD
Genentech, Inc.

Lee N. Newcomer, MD, MHA
United Healthcare

Lynn Zonakis
Delta Airlines

Panel members subject to change

Click here to register for the NCCN 14th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ March 11 – 15, 2009 or to view additional agenda topics.